Sleep Therapy for Dementia
(SLEEPMATE Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine if a 6-week videoconference intervention to teach skills to improve sleep is practical, acceptable, and helpful to persons living with memory loss, cognitive impairment, and/or dementia and care partners, individually or together.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia (CBT-I) for sleep disturbances in dementia patients?
Is digital cognitive behavioral therapy for insomnia safe for humans?
How is the treatment Cognitive Behavioral Therapy for Insomnia (CBT-I) unique for dementia patients?
CBT-I is unique because it is a non-drug treatment that uses digital tools to help improve sleep quality by changing thoughts and behaviors related to sleep. Unlike medications, it focuses on long-term improvements in sleep and overall well-being without the side effects associated with sleep drugs.25679
Research Team
Glenna Brewster, PhD, RN, FNP
Principal Investigator
Emory University
Eligibility Criteria
This trial is for older adults experiencing memory loss, cognitive impairment, or dementia and their care partners. They should be willing to participate in a 6-week videoconference program aimed at improving sleep.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week CBTi intervention via videoconferencing sessions
Follow-up
Participants are monitored for changes in sleep onset latency, insomnia, sleep efficiency, and other outcomes
Treatment Details
Interventions
- Cognitive Behavioral Therapy for Insomnia (Behavioral Intervention)
Cognitive Behavioral Therapy for Insomnia is already approved in United States, European Union, United States, United Kingdom for the following indications:
- Insomnia
- Depression
- Insomnia
- Depression
- Chronic Insomnia
- Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator